1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Intravenous Immunoglobulin Market – By Type

1.3.2        APAC Intravenous Immunoglobulin Market – By Application

1.3.3        APAC Intravenous Immunoglobulin Market – By Distribution Channel

1.3.4        APAC Intravenous Immunoglobulin Market – By End User

1.3.5        APAC Intravenous Immunoglobulin Market – By Country

2.           APAC Intravenous Immunoglobulin Market– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Intravenous Immunoglobulin Market – Market Landscape

4.1         Overview

4.2         APAC PEST Analysis

4.3         Expert Opinion

5.           APAC Intravenous Immunoglobulin Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Immunodeficiency Diseases

5.1.2        Increasing Geriatric Population

5.2         Market Restraints

5.2.1        Adverse Effects of Immunoglobulin Therapy

5.3         Market Opportunities

5.3.1        Growing Pharmaceutical Industry

5.4         Future Trends

5.4.1        Strong Pipeline Candidates for IVIG

5.5         Impact Analysis

6.           Intravenous Immunoglobulin Market– APAC Analysis

6.1         APAC Intravenous Immunoglobulin Market Revenue Forecast and Analysis

7.           APAC Intravenous Immunoglobulin Market Revenue and Forecast to 2028– by Type

7.1         Overview

7.2         APAC Intravenous Immunoglobulin Market, By Type 2022 & 2028 (%)

7.3         IgG

7.3.1        Overview

7.3.2        IgG Revenue and Forecast to 2028 (US$ Million)

7.4         IgM

7.4.1        Overview

7.4.2        IgM - Revenue and Forecast to 2028 (US$ Million)

7.5         IgA

7.5.1        Overview

7.5.2        IgA - Revenue and Forecast to 2028 (US$ Million)

7.6         IgE

7.6.1        Overview

7.6.2        IgE - Revenue and Forecast to 2028 (US$ Million)

7.7         IgD

7.7.1        Overview

7.7.2        IgD - Revenue and Forecast to 2028 (US$ Million)

8.           APAC Intravenous Immunoglobulin Market Revenue and Forecast to 2028 – by Application

8.1         Overview

8.2         APAC Intravenous Immunoglobulin Market, By Application 2022 & 2028 (%)

8.3         Hypogammaglobulinemia

8.3.1        Overview

8.3.2        Hypogammaglobulinemia - Market Revenue and Forecast to 2028 (US$ Million)

8.4         Chronic Inflammatory Demyelinating Polyneuropathy

8.4.1        Overview

8.4.2        Chronic Inflammatory Demyelinating Polyneuropathy - Market Revenue and Forecast to 2028 (US$ Million)

8.5         Immunodeficiency Diseases

8.5.1        Overview

8.5.2        Immunodeficiency Diseases - Market Revenue and Forecast to 2028 (US$ Million)

8.6         Myasthenia Gravis

8.6.1        Overview

8.6.2        Myasthenia Gravis - Market Revenue and Forecast to 2028 (US$ Million)

8.7         Multifocal Motor Neuropathy

8.7.1        Overview

8.7.2        Multifocal Motor Neuropathy - Market Revenue and Forecast to 2028 (US$ Million)

8.8         Idiopathic Thrombocytopenic Purpura

8.8.1        Overview

8.8.2        Idiopathic Thrombocytopenic Purpura - Market Revenue and Forecast to 2028 (US$ Million)

8.9         Inflammatory Myopathies

8.9.1        Overview

8.9.2        Inflammatory Myopathies - Market Revenue and Forecast to 2028 (US$ Million)

8.10      Specific Antibody Deficiency

8.10.1     Overview

8.10.2     Specific Antibody Deficiency - Market Revenue and Forecast to 2028 (US$ Million)

8.11      Guillain-Barre Syndrome

8.11.1     Overview

8.11.2     Guillain-Barre Syndrome - Market Revenue and Forecast to 2028 (US$ Million)

8.12      Others

8.12.1     Overview

8.12.2     Others - Market Revenue and Forecast to 2028 (US$ Million)

9.           APAC Intravenous Immunoglobulin Market Revenue and Forecast to 2028 – by Distribution Channel

9.1         Overview

9.2         APAC Intravenous Immunoglobulin Market, By Distribution Channel 2022 & 2028 (%)

9.3         Hospital Pharmacy

9.3.1        Overview

9.3.2        Hospital Pharmacy - Market Revenue and Forecast to 2028 (US$ Million)

9.4         Retail Pharmacy

9.4.1        Overview

9.4.2        Retail Pharmacy - Market Revenue and Forecast to 2028 (US$ Million)

9.5         Others

9.5.1        Overview

9.5.2        Others - Market Revenue and Forecast to 2028 (US$ Million)

10.        APAC Intravenous Immunoglobulin Market Revenue and Forecast to 2028 – by End User

10.1      Overview

10.2      APAC Intravenous Immunoglobulin Market, By End User 2022 & 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)

10.4      Specialty Clinics

10.4.1     Overview

10.4.2     Specialty Clinics - Market Revenue And Forecasts To 2028 (US$ Million)

10.5      Others

10.5.1     Overview

10.5.2     Others - Market Revenue And Forecasts To 2028 (US$ Million)

11.        APAC Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 – Country Analysis

11.1      Overview

11.1.1     Asia Pacific: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)

11.1.1.1       China: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.1       Overview

11.1.1.1.2       China: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.3       China: Intravenous Immunoglobulin Market, By Type – 2019–2028 (US$ Million)

11.1.1.1.4       China: Intravenous Immunoglobulin Market, by Application – 2019–2028 (US$ Million)

11.1.1.1.5       China: Intravenous Immunoglobulin Market, By Distribution Channel – 2019–2028 (US$ Million)

11.1.1.1.6       China: Intravenous Immunoglobulin Market, by End User – 2019–2028 (US$ Million)

11.1.1.2       Japan: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.1       Overview

11.1.1.2.2       Japan: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.3       Japan: Intravenous Immunoglobulin Market, By Type – 2019–2028 (US$ Million)

11.1.1.2.4       Japan: Intravenous Immunoglobulin Market, by Application – 2019–2028 (US$ Million)

11.1.1.2.5       Japan: Intravenous Immunoglobulin Market, By Distribution Channel – 2019–2028 (US$ Million)

11.1.1.2.6       Japan: Intravenous Immunoglobulin Market, by End User – 2019–2028 (US$ Million)

11.1.1.3       India Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.1       Overview

11.1.1.3.2       India: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.3       India: Intravenous Immunoglobulin Market, By Type – 2019–2028 (US$ Million)

11.1.1.3.4       India: Intravenous Immunoglobulin Market, by Application – 2019–2028 (US$ Million)

11.1.1.3.5       India: Intravenous Immunoglobulin Market, By Distribution Channel – 2019–2028 (US$ Million)

11.1.1.3.6       India: Intravenous Immunoglobulin Market, by End User – 2019–2028 (US$ Million)

11.1.1.4       Australia: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.1       Overview

11.1.1.4.2       Australia: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.3       Australia: Intravenous Immunoglobulin Market, By Type – 2019–2028 (US$ Million)

11.1.1.4.4       Australia: Intravenous Immunoglobulin Market, by Application – 2019–2028 (US$ Million)

11.1.1.4.5       Australia: Intravenous Immunoglobulin Market, By Distribution Channel – 2019–2028 (US$ Million)

11.1.1.4.6       Australia: Intravenous Immunoglobulin Market, by End User – 2019–2028 (US$ Million)

11.1.1.5       South Korea: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.5.1       Overview

11.1.1.5.2       South Korea: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.5.3       South Korea: Intravenous Immunoglobulin Market, By Type – 2019–2028 (US$ Million)

11.1.1.5.4       South Korea: Intravenous Immunoglobulin Market, by Application – 2019–2028 (US$ Million)

11.1.1.5.5       South Korea: Intravenous Immunoglobulin Market, By Distribution Channel – 2019–2028 (US$ Million)

11.1.1.5.6       South Korea: Intravenous Immunoglobulin Market, by End User – 2019–2028 (US$ Million)

11.1.1.6       Rest of Asia Pacific: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.1       Overview

11.1.1.6.2       Rest of Asia Pacific: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.6.3       Rest of Asia Pacific: Intravenous Immunoglobulin Market, By Type – 2019–2028 (US$ Million)

11.1.1.6.4       Rest of Asia Pacific: Intravenous Immunoglobulin Market, by Application – 2019–2028 (US$ Million)

11.1.1.6.5       Rest of Asia Pacific: Intravenous Immunoglobulin Market, By Distribution Channel – 2019–2028 (US$ Million)

11.1.1.6.6       Rest of Asia Pacific: Intravenous Immunoglobulin Market, by End User – 2019–2028 (US$ Million)

12.        APAC Intravenous Immunoglobulin Market–Industry Landscape

12.1      Overview

12.2      Inorganic Growth Strategies

12.2.1     Overview

12.3      Organic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      Takeda Pharmaceutical Company Limited

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Grifols, S.A.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Pfizer Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      ADMA Biologics, Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Bio Products Laboratory Ltd.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Shanghai RAAS

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Octapharma AG

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Kedrion S.p.A

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      CSL Behring (CSL Limited)

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Prothya Biosolutions B.V.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms in Intravenous Immunoglobulin Market

LIST OF TABLES

Table 1.             APAC Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             China: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million).

Table 3.             China: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 4.             China: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 5.             China: Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Japan: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million).

Table 7.             Japan: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Japan: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Japan: Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 10.          India: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million).

Table 11.          India: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 12.          India: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028  (US$ Million)

Table 13.          India: Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Australia: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million).

Table 15.          Australia: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Australia: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Australia: Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 18.          South Korea: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million).

Table 19.          South Korea: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 20.          South Korea: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 21.          South Korea: Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Rest of Asia Pacific: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (US$ Million).

Table 23.          Rest of Asia Pacific: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Rest of Asia Pacific: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Rest of Asia Pacific: Intravenous Immunoglobulin Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 26.          Recent Inorganic Growth Strategies in the Intravenous Immunoglobulin Market

Table 27.          Recent Organic Growth Strategies in the Intravenous Immunoglobulin Market

Table 28.          Glossary of Terms in Intravenous Immunoglobulin Market

LIST OF FIGURES

Figure 1.           APAC Intravenous Immunoglobulin Market Segmentation

Figure 2.           APAC Intravenous Immunoglobulin Market Segmentation, By Country

Figure 3.           APAC Intravenous Immunoglobulin Market Overview

Figure 4.           APAC Intravenous Immunoglobulin Market, by Type

Figure 5.           APAC Intravenous Immunoglobulin Market, by Country

Figure 6.           Asia Pacific: PEST Analysis

Figure 7.           Impact Analysis

Figure 8.           APAC Intravenous Immunoglobulin Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 9.           APAC Intravenous Immunoglobulin Market, by Type 2022 & 2028 (%)

Figure 10.        APAC IgG Revenue and Forecasts to 2028 (US$ Million)

Figure 11.        APAC IgM - Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        APAC IgA - Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        APAC IgE - Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        APAC IgD - Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        APAC Intravenous Immunoglobulin Market, by Application 2022 & 2028 (%)

Figure 16.        APAC Hypogammaglobulinemia - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        APAC Chronic Inflammatory Demyelinating Polyneuropathy - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        APAC Immunodeficiency Diseases - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        APAC Myasthenia Gravis - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        APAC Multifocal Motor Neuropathy - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        APAC Idiopathic Thrombocytopenic Purpura - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        APAC Inflammatory Myopathies - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        APAC Specific Antibody Deficiency - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        APAC Guillain-Barre Syndrome - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        APAC Others - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        APAC Intravenous Immunoglobulin Market, by Distribution Channel 2022 & 2028 (%)

Figure 27.        APAC Hospital Pharmacy - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        APAC Retail Pharmacy - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        APAC Others - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30.        APAC Intravenous Immunoglobulin Market, by End User 2022 & 2028 (%)

Figure 31.        APAC Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 32.        APAC Specialty Clinics - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 33.        APAC Others- Market Revenue And Forecasts To 2028 (US$ Million)

Figure 34.        Asia Pacific Intravenous Immunoglobulin Market Overview, by Country (2022)

Figure 35.        Asia Pacific: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)

Figure 36.        China: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37.        Japan: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38.        India: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)

Figure 39.        Australia: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)

Figure 40.        South Korea: Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 (US$ Million)

Figure 41.          Rest of Asia Pacific: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)